Qinzhuliangxue mixture alleviates psoriasis-like skin lesions via inhibiting the IL6/STAT3 axis
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 274, 114041
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 32 references indexed in Scilit:
- Patients with psoriasis are insulin resistantJournal of the American Academy of Dermatology, 2015
- Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?Arthritis Research & Therapy, 2014
- Acacetin Blocks Kv1.3 Channels and Inhibits Human T Cell ActivationCellular Physiology and Biochemistry, 2014
- TNFα‐ and IL‐17A‐mediated S100A8 expression is regulated by p38 MAPKExperimental Dermatology, 2013
- Induction and molecular signature of pathogenic TH17 cellsNature Immunology, 2012
- CD4 + Regulatory T Cells Control T H 17 Responses in a Stat3-Dependent MannerScience, 2009
- Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skinBritish Journal of Dermatology, 2009
- Network pharmacology: the next paradigm in drug discoveryNature Chemical Biology, 2008
- TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathologyNature Immunology, 2007
- Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-κB activationBiochemical Pharmacology, 2000